Pierantonio Menna

9PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Haematological tumoursAnimal behaviourPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 02, 2025
Correction: Fixed-duration therapy of chronic lymphocytic leukemia with venetoclax and Bruton tyrosine kinase inhibitors: an insight into differences between ibrutinib and acalabrutinib.

Alessandra Tedeschi, Anna Maria Frustaci, Pierantonio Menna

|Nov 03, 2025
Correction: Fixed-duration therapy of chronic lymphocytic leukemia with venetoclax and Bruton tyrosine kinase inhibitors: an insight into differences between ibrutinib and acalabrutinib.

Alessandra Tedeschi, Anna Maria Frustaci, Pierantonio Menna

|Oct 20, 2025
Adjudication of Adverse Cardiovascular Events in Patients with Chronic Lymphocytic Leukaemia Treated with Ibrutinib: Deaths in GLOW or Blowing in the Wind?

Roberta Esposito, Pierantonio Menna, Emanuela Salvatorelli

|Oct 02, 2025
Fixed-duration therapy of chronic lymphocytic leukemia with venetoclax and Bruton tyrosine kinase inhibitors: an insight into differences between ibrutinib and acalabrutinib.

Alessandra Tedeschi, Anna Maria Frustaci, Pierantonio Menna

|Nov 19, 2024
Humans and Rodents: The Case of hOAT4 and mOat5.

Pierantonio Menna, Emanuela Salvatorelli

|Feb 24, 2024
Quantitative Analysis of Cenobamate and Concomitant Anti-Seizure Medications in Human Plasma via Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry.

Linda Molteni, Bruno Charlier, Albino Coglianese

Pageof 2

Frequent Collaborators

5 joint publications

Giorgio Minotti

2 joint publications

Francesco Marchesi

2 joint publications

Bruno Charlier

2 joint publications

Ugo de Grazia